Tagged with HAI

Mexico COVID-19 has highlighted the importance of secure regional pharma supply chains across the globe, not least in Mexico where the state of Hidalgo has signed a deal with six Indian generics firms to establish a pharma hub for manufacturing and logistics.   One of the leading pharma markets in Latin…

Coronavirus During the fourth International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) COVID-19 media briefing, one thematic dominated: collaboration. With Eli Lilly chairman and CEO David Ricks, also president of IFPMA; Roche CEO Dr Severin Schwan, also vice-president of IFPMA; Pfizer chairman and CEO Dr Albert Bourla; MSD (Merck & Co.…

Merck PharmaBoardroom recently sat down with Merck’s EVP and Head of Global Healthcare Operations, Teresa Rodó to unpack her important role within the global group and how Merck has pivoted to rise to the supply chain challenges posed by the COVID-19 crisis.   Although many companies now claim to have this…

Merck Teresa Rodó gives an overview of her role overseeing the development, manufacturing, supply, and quality of all of Merck’s biotech and pharmaceutical medicines and medical devices. Rodó also explains how the company has been able to withstand the supply chain challenges posed by the COVID-19 pandemic, and why Merck is…

Vaccines Jeremy Farrar, director of the Wellcome Trust, spoke to Financial Times correspondent Vanessa Kortekaas on 25 June 2020 about the global race to develop a COVID-19 vaccine. He emphasized the importance of prioritising access to at-risk populations, supply chain scale issues that must be considered, why there is no future…

South Africa Below is a roundup of latest news from South Africa’s life sciences and healthcare industries, including a call to overhaul patent laws to allow better access to COVID-19 drugs, innovation for HIV and TB medication adherence, COVID-19 vaccine trials, gut microbiome testing and supply chain lessons from the pandemic.  …

Brazil The editorial team at Panorama Farmaceutico explain how the COVID-19 pandemic and global trade flow stoppages are impacting the manufacture and supply of medicines within Brazil.*   The COVID-19 pandemic has again brought to the fore Brazil’s need to reduce its dependence on active pharmaceutical ingredients (APIs) from abroad. Brazil imports…

Thailand On February 19, 2019, by amending the Narcotics Act B.E. 2522, Thailand caught the cannabis industry by surprise and became the first Asia-Pacific country to legalize medicinal cannabis. While hemp had been approved for use in industry since 2018 (see here), the amendment of the Narcotics Act B.E. 2522, providing for…

China Dr Sharon Chan, head of JLABS @ Shanghai – the first JLABS presence in Asia-Pacific as well as the largest globally – shares how Johnson & Johnson is investing in the innovation ecosystem in China and the APAC region; some of the key milestones over the past year; and her…

Thailand Dealing with the COVID-19 pandemic has taken top priority for almost every country in the world. In Thailand, even though the strength of the country’s health security measures has been ranked sixth-best globally, COVID-19 has hit hard, and the number of confirmed cases is steadily increasing each day.   In…

Opinion Becton Dickinson’s Fiona Garín looks at the rise of Healthcare-Acquired Infections (HAIs) in Europe and how an industry-wide culture of safety needs to be developed to counter this growing threat.   Healthcare systems in Europe are becoming more complex in their quest to drive affordability, quality of care and patient…

Thailand PharmaBoardroom’s latest report: Healthcare & Life Sciences Review: Thailand is available for download now.   Thailand is in the midst of an economic transformation with healthcare at its heart. With four years of around three-four percent annual GDP growth behind it, ASEAN’s second-largest economy has implemented an ‘Industry 4.0’ policy through which…